A Comparative Analysis of Pancreatic Tumor Detection using VGG16, ResNet, and DenseNet

This study explores the transformative potential of image classification algorithms like VGG16, ResNet, and DenseNet, for the early detection of pancreatic tumors using medical imaging. One of the main causes of cancer-related deaths globally is pancreatic cancer. However, pancreatic cancer detected at early stages can be cured. This study navigates through the evolution of CNNs in medical image analysis and their specific applications in pancreatic cancer detection. Pancreatic cancer poses a significant global health challenge due to its high mortality rates, often attributed to late-stage detection. The primary objective is to enhance diagnostic accuracy and enable timely intervention. The obtained results demonstrated promising accuracy levels for each model. VGG16 achieved an accuracy of 96%, ResNet demonstrated an accuracy of 98.31%, and DenseNet showcased an accuracy of 99%. Precision values for VGG16, ResNet, and DenseNet were 95%, 96%, and 95.2%, respectively. Recall values were 98% for VGG16, 95% for ResNet, and 97% for DenseNet. The F1 score for 98% for VGG16, 97% for ResNet, and 98.1% for DenseNet. The study concludes that VGG16, ResNet, and DenseNet are valuable tools for pancreatic tumor detection, with each architecture exhibiting unique advantages. By aiding in the early detection of pancreatic cancer, the suggested models may enhance patient outcomes. The research provides insights into the comparative performance of these deep learning architectures, guiding future developments in medical image analysis.